Agios Pharma (GB:0HB0)

Agios Pharma (0HB0) Stock Price & Analysis


0HB0 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$17.09 - $34.57
Previous Close$25.68
Average Volume (3M)156.00
Market Cap
Enterprise Value$778.23M
Total Cash (Recent Filing)$739.20M
Total Debt (Recent Filing)$82.34M
Price to Earnings (P/E)N/A
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding55,580,791
10 Day Avg. Volume35
30 Day Avg. Volume156
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)1.42
Price to Sales (P/S)469.93
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue52.92
Enterprise Value/Gross Profit62.08
Enterprise Value/Ebitda-2.86
Price Target Upside50.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4




What was Agios Pharma’s price range in the past 12 months?
Agios Pharma lowest stock price was $17.09 and its highest was $34.57 in the past 12 months.
    What is Agios Pharma’s market cap?
    Currently, no data Available
    When is Agios Pharma’s upcoming earnings report date?
    Agios Pharma’s upcoming earnings report date is Aug 03, 2023 which is in 66 days.
      How were Agios Pharma’s earnings last quarter?
      Agios Pharma released its earnings results on May 04, 2023. The company reported -$1.47 earnings per share for the quarter, beating the consensus estimate of -$1.701 by $0.231.
        Is Agios Pharma overvalued?
        According to Wall Street analysts Agios Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Agios Pharma pay dividends?
          Agios Pharma does not currently pay dividends.
          What is Agios Pharma’s EPS estimate?
          Agios Pharma’s EPS estimate is -$1.56.
            How many shares outstanding does Agios Pharma have?
            Currently, no data Available
            What happened to Agios Pharma’s price movement after its last earnings report?
            Agios Pharma reported an EPS of -$1.47 in its last earnings report, beating expectations of -$1.701. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Agios Pharma?
              Among the largest hedge funds holding Agios Pharma’s share is Farallon Capital Management, L.L.C.. It holds Agios Pharma’s shares valued at 48M.


                Agios Pharma Stock Smart Score

                The Agios Pharma Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Agios Pharma

                Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Catalyst Pharma
                Prime Medicine, Inc.
                Recursion Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis